Peptides, Made to Order

The use of synthetic peptides in life science research is growing as researchers in a wide variety of disciplines find applications for these reagents. Many of these peptides are easily produced by automated peptide synthesis, which enables the economic and relatively easy production of peptides in large quantities. As a result, many widely used, biologically active peptides are commercially available as pre-made catalog reagents.1 But when experimental approaches call for peptides that are not

Written byDeborah Fitzgerald
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

For academic researchers, many universities and institutes maintain their own core facilities for peptide synthesis. When such facilities are not available, or when they do not offer the exact services needed (e.g., a specific type of synthesis or desired quality control measure), an investigator can turn to one of the many external commercial sources. This profile details the various options that should be considered when choosing a custom peptide facility, including some general questions that should be addressed. Specific information about companies providing custom peptide synthesis services is presented in the accompanying table.

Researchers familiar with using custom services know that reputation, built from consistent results and word-of-mouth from other scientists, is perhaps the best way to estimate the quality of work done by a particular company. Researchers should also evaluate how closely each candidate matches the desired services, timeline, and budgetary constraints. There are many companies to choose from, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies